Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT03125239 · COMPLETED
Trial details
- NCT number
- NCT03125239
- Sponsor
- Jacqueline Garcia, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-10
- Primary completion
- 2020-06-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.